LC
IONS icon

Lindbrook Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Lindbrook Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$13.3K Sell
440
-596
-58% -$19.5K ﹤0.01% 1535
2024
Q4 		$36.2K Buy
1,036
+671
+184% +$25.1K ﹤0.01% 952
2024
Q3 		$14.6K Sell
365
-24
-6% -$1.12K ﹤0.01% 1477
2024
Q2 		$18.5K Buy
389
+75
+24% +$3.08K ﹤0.01% 1287
2024
Q1 		$13.6K Sell
314
-79
-20% -$3.77K ﹤0.01% 1398
2023
Q4 		$19.9K Buy
393
+85
+28% +$4.07K ﹤0.01% 1179
2023
Q3 		$14K Sell
308
-38
-11% -$1.57K ﹤0.01% 1243
2023
Q2 		$14.2K Buy
346
+106
+44% +$4.07K ﹤0.01% 1265
2023
Q1 		$8.58K Buy
240
+125
+109% +$4.69K ﹤0.01% 1546
2022
Q4 		$4.34K Sell
115
-68
-37% -$2.86K ﹤0.01% 1893
2022
Q3 		$8K Buy
183
+126
+221% +$5.31K ﹤0.01% 1430
2022
Q2 		$2K Hold
57
– – ﹤0.01% 1978
2022
Q1 		$2K Buy
57
+37
+185% +$1.21K ﹤0.01% 2014
2021
Q4 		$1K Sell
20
-82
-80% -$2.58K ﹤0.01% 1937
2021
Q3 		$3K Buy
102
+86
+538% +$3.24K ﹤0.01% 1417
2021
Q2 		$1K Sell
16
-30
-65% -$1.18K ﹤0.01% 1776
2021
Q1 		$2K Hold
46
– – ﹤0.01% 1556
2020
Q4 		$3K Buy
+46
New +$2.29K ﹤0.01% 1341
2020
Q3 		– Sell
-20
Closed -$1.11K – 1794
2020
Q2 		$1K Hold
20
– – ﹤0.01% 1571
2020
Q1 		$1K Buy
+20
New +$1.11K ﹤0.01% 1477
2019
Q3 		– Sell
-44
Closed -$2K – 1477
2019
Q2 		$2K Hold
44
– – ﹤0.01% 1236
2019
Q1 		$3K Hold
44
– – ﹤0.01% 1166
2018
Q4 		$2K Buy
+44
New +$2.24K ﹤0.01% 1174

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lindbrook Capital's IONS Position: Q1 2025 in Review

Lindbrook Capital reduced its Ionis Pharmaceuticals (IONS) stake by 58% in Q1 2025, selling an estimated $19.5K and leaving 440 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Lindbrook Capital first reported a position in IONS in Q4 2018 and has held it in 23 quarters since. The position peaked at $36.2K in Q4 2024. 344 funds tracked by Wall St. Rank hold IONS as of Q1 2025.

  • Lindbrook Capital held 440 shares of Ionis Pharmaceuticals worth $13.3K as of Q1 2025.
  • Lindbrook Capital sold 596 Ionis Pharmaceuticals shares in Q1 2025, an estimated $19.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1535 holding.
  • Lindbrook Capital first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 23 quarters since.
  • Lindbrook Capital's Ionis Pharmaceuticals position peaked at $36.2K in Q4 2024.
  • 344 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.